openPR Logo
Press release

Antacids Sector Dynamics: Factors Driving the US$ 22 Billion Market by 2033

03-19-2024 10:13 PM CET | Chemicals & Materials

Press release from: Fact.MR

Antacids Market

Antacids Market

According to a report from Fact.MR, the global antacids market was worth US$ 14 billion in 2023. The market is expected to grow and reach a size of US$ 22 billion by 2033. This means the market is projected to increase at a rate of 4.6% annually from 2023 to 2033.

๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4328

Antacids, the go-to remedy for heartburn and indigestion, have long been a staple in households worldwide. From chalky tablets to fruity-flavored liquids, these over-the-counter medications provide quick relief for those uncomfortable moments after a heavy meal or a spicy dish. But what drives the growth of this industry, and what does the future hold for antacids?

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐˜€:

Changing Lifestyles:

In today's fast-paced world, people often resort to fast food and irregular eating habits. These lifestyle changes contribute to an increase in digestive issues like acid reflux and heartburn, leading to a higher demand for antacids.

Aging Population:

With the global population aging, the prevalence of gastrointestinal problems also rises. Older adults are more prone to conditions like gastroesophageal reflux disease (GERD), prompting them to rely on antacids for relief.

Increased Awareness:

As information becomes more accessible, people are becoming increasingly aware of the symptoms and treatment options for digestive disorders. This heightened awareness drives individuals to seek relief from over-the-counter antacids.

Innovation and Product Development:

The antacid industry continuously innovates to cater to evolving consumer preferences. From chewable tablets to liquid gels, manufacturers strive to offer convenient and effective solutions for acid-related discomfort.

Globalization:

Antacids are not confined to specific regions but have a global market. As urbanization spreads and access to healthcare improves in developing countries, the demand for antacids is expected to rise.

๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ:

Technological Advancements:

The future of antacids may see advancements in formulation techniques and delivery methods. Innovations such as nanoencapsulation could enhance the efficacy and duration of antacid effects.

Personalized Medicine:

With the advent of personalized medicine, antacids tailored to individual needs could become a reality. Genetic testing and biomarker analysis may enable healthcare providers to prescribe specific antacid formulations optimized for each patient.

Natural Remedies:

The shift towards natural and herbal remedies may influence the antacid market. Manufacturers may explore plant-based ingredients and traditional remedies with proven efficacy in soothing digestive discomfort.

Digital Health Solutions:

Technology-driven solutions like mobile applications and wearable devices could revolutionize how individuals manage digestive health. These platforms may provide personalized dietary recommendations and track symptoms, complementing the use of antacids.

Environmental Sustainability:

Concerns about environmental sustainability are prompting manufacturers to develop eco-friendly packaging and production processes. Biodegradable materials and energy-efficient manufacturing practices may shape the future of the antacid industry.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐—™๐—ผ๐—ฟ ๐—™๐—ฅ๐—˜๐—˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4328

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€:

Bayer AG
GlaxoSmithKline plc
Mylan N.V.
Novartis AG
Sanofi
Procter & Gamble
Reddy's Laboratories Ltd.
Reckitt Benckiser Group plc
Sun Pharmaceuticals Ltd.
Takeda Pharmaceutical Company Limited
Pfizer Inc.

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ:

Top companies are using various strategies like forming partnerships, ensuring quality, buying other companies, setting product standards, managing how products get to customers, and working together with others. They're doing this to sell more in different places and be better than their rivals. Big antacid makers are busy making new things and bringing them out while being careful to follow the rules about safety to keep customers happy.

For example,

In 2020, Lupin started selling Horizon Therapeutics PLC's Vimovo delayed-release tablets. These tablets help lessen the chance of getting stomach ulcers from taking naproxen.

๐—•๐—ฟ๐—ผ๐˜„๐˜€๐—ฒ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ @ https://www.factmr.com/report/4328/antacids-market

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

By Drug Class :
Proton Pump Inhibitors
H2 Antagonists
Acid Neutralizers

By Formulation :
Tablets
Liquid
Powder
Others

By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region :
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ฒ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฅ๐—ฒ๐—น๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ฆ๐˜๐˜‚๐—ฑ๐—ถ๐—ฒ๐˜€ ๐—ฃ๐˜‚๐—ฏ๐—น๐—ถ๐˜€๐—ต๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—™๐—ฎ๐—ฐ๐˜.๐— ๐—ฅ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต:

Glycobiology Market:

https://www.factmr.com/report/glycobiology-market

Endodontic Reparative Cement Market:

https://www.factmr.com/report/endodontic-reparative-cement-market

IV Infusion Pump Accessories Market:

https://www.factmr.com/report/iv-infusion-pump-accessories-market

Canine Stem Cell Therapy Market:

https://www.factmr.com/report/canine-stem-cell-therapy-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Sector Dynamics: Factors Driving the US$ 22 Billion Market by 2033 here

News-ID: 3436908 • Views: โ€ฆ

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 โ€ฆ
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent needโ€ฆ
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L โ€ฆ
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements inโ€ฆ
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc โ€ฆ
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by risingโ€ฆ
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% โ€ฆ
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourcedโ€ฆ

All 5 Releases


More Releases for Antacids

Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market: โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Antacids Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the antacids market has been demonstrating steady growth. The market value is projected to increase from $9.63 billion in 2024 to $9.94 billion in 2025, exhibiting a Compound Annual Growth Rateโ€ฆ
Mouth-Melting Antacids Revolutionize The Market Industry Trends Gaining Momentum โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Antacids Market Through 2025? In the past few years, the size of the antacids market has demonstrably increased. It is projected to rise from $9.54 billion in 2024 to $9.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.8%.โ€ฆ
Antacids Tablets Market Future Prediction Report By 2033
The Antacids Tablets Market was valued at USD 6.92 billion in 2023, and it is projected to reach USD 12.01 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033. Antacids Tablets Market Overview The Antacids Tablets Market is experiencing steady growth due to the rising prevalence of acid reflux, indigestion, and gastrointestinal disorders across the globe. Increasing consumption of fast food, stressful lifestyles, and higher awareness about digestiveโ€ฆ
Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market: โ€ฆ
The Antacids Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Antacids Market Size and Projected Growth Rate? The market for antacids has experienced consistent growth in the past few years. The market's value is predicted to escalate from $9.54 billion in 2024 toโ€ฆ
North America Antacids Market Prospects and Growth Assessment 2027
The North America antacids market is expected to reach US$ 3,564.22 million in 2027 from US$ 2,684.67 million in 2019. The market is estimated to grow with a CAGR of 3.7% from 2020-2027. The Report North America Antacids Market study by "Business Market Insights" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape andโ€ฆ
Antacids Market Growth Size, Share |Trend 2030
Exclusive Report by Ameco Research: Antacids Market Size Projected to Reach USD 10 Billion by 2030, Growing at 4.40% CAGR Ameco Research is proud to announce the launch of its latest market research report, Antacids Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research reports toโ€ฆ